brief psychotic disorder
Recently Published Documents


TOTAL DOCUMENTS

67
(FIVE YEARS 26)

H-INDEX

7
(FIVE YEARS 2)

2022 ◽  
Vol 27 ◽  
pp. 100214
Author(s):  
Zeinab El Nagar ◽  
Heba H. El Shahawi ◽  
Safeya M. Effat ◽  
Mona M. El Sheikh ◽  
Ahmed Adel ◽  
...  

2022 ◽  
Vol 2022 ◽  
pp. 1-3
Author(s):  
Sulaimon Bakre ◽  
Kritika Chugh ◽  
Oluwaseun Oke ◽  
Anita Kablinger

The COVID-19 pandemic has significantly impacted people around the world, with asymptomatic infection to severe diseases and death. There is an increasing incidence of mental health problems in patients diagnosed with COVID-19. There are some studies that discuss possible mechanisms responsible for psychotic disorders due to coronavirus as well as risk factors for developing psychosis in patients infected with the virus. We report the case and a review of the literature in a 29-year-old female with no past psychiatric history who was diagnosed with a brief psychotic disorder following infection with COVID-19.


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Julita Poleszak-Szabat ◽  
Małgorzata Romaniuk-Suswał ◽  
Paweł Krukow

Abstract Introduction: Although the typical symptoms of SARS-CoV-2 infection are respiratory symptoms, it has been shown that the virus can also attack the central nervous system (CNS) causing neurological and psychiatric symptoms. Aim: The aim of the study was to present a case of a 52-year-old woman, previously untreated for psychiatric diseases, who developed brief psychotic disorder occurring after Covid-19 infection. Case report: A patient in the biological treatment of asthma, came for a follow-up visit, during which the doctor diagnosed psychopathological symptoms in the form of delusions, never previously observed. The interview showed that the patient was discharged from the Isolation ward 10 days before, where she was hospitalized because of SARS-CoV-2 infection. Discussion: There are several theories regarding the mechanisms of pathogenesis of neuropsychiatric symptoms in the course of Covid-19 infection. Much space in the literature is devoted to pathological immune responses. One of the reasons for the development of delusions in the described patient could therefore be the acute phase of the inflammatory reaction in the course of SARS-CoV-2 infection.


2021 ◽  
pp. 1-6
Author(s):  
Augusto C. Castagnini ◽  
German E. Berrios

Short-lived psychotic disorders as currently listed under “acute and transient psychotic disorder,” ICD-11 Classification of Mental, Behavioural, and Neurodevelopmental Disorders, and “brief psychotic disorder,” Diagnostic and Statistical Manual of Mental Disorders (DSM-5), constitute a point of divergence in the classification of psychotic disorders between the 2 diagnostic systems, which reveals the lack of knowledge about these conditions. Whether this is due to conceptual shortcomings inherent to the categories themselves and which spill over onto research or reflects a mismatch between the diagnostic criteria used and research techniques needs clarification. This study aimed to examine conceptual issues involved in the development of the above categories and shows that little continuity exists between earlier nosological concepts such as bouffée délirante, cycloid psychosis, and reactive psychosis and modern descriptive categories used to classify short-lived psychotic disorders. It seems likely that shortcomings in terms of symptom completeness, specificity, and heterogeneity, in addition to changes in definition and diagnostic criteria in successive DSM and ICD versions, have hampered empirical research, making it difficult to enhance the understanding of these conditions and achieve a closer concordance between the 2 classificatory systems.


Author(s):  
Jalal Doufik ◽  
Said Boujraf ◽  
Mina Ouhmou ◽  
Hicham Laaraj ◽  
Khalid Mouhadi ◽  
...  

Background: COVID-19 virus outbreak appeared in December 2019 and was announced as pandemic by the World Health Organization (WHO) in March 2020. Recent cases of reactive psychosis in the context of the COVID-19 pandemic have been reported. However, there was reduced interest attributed to cases of acute psychosis affecting patients with COVID-19. In here, we present a clinical case of a female patient who showed a brief psychotic disorder during a symptomatic infection with COVID-19. Methods: We discuss the differential diagnosis of brief psychotic disorder with marked stressor and neuropsychiatric symptoms of COVID-19 infection. Although the stress factor appeared to be linked to the acute psychosis onset in our COVID-19 positive patient, the diagnosis of a psychotic disorder due to the viral coronavirus infection is worthing to be reported and discussed. Results and Conclusion: The stress factor appears to be linked to the onset of acute psychosis in this COVID-19 positive patient, the diagnosis of a psychotic disorder due to the viral coronavirus infection is worth to be mentioned. Thus, we suggest that a new psychosis case associated with COVID-19 infection due to potential immune-mediated neuropathogenesis that would justify further investigation. Through this case report, we highlight the need for vigilant monitoring of neuropsychiatric symptoms in individuals with COVID-19 infections.


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Dmitriy V. Ivashchenko ◽  
Daria A. Yudelevich ◽  
Nina I. Buromskaya ◽  
Pavel V. Shimanov ◽  
Roman V. Deitch ◽  
...  

Abstract Objectives To identify possible associations of CYP2D6, CYP3A4/5, and ABCB1 gene polymorphisms with the efficacy and safety of antipsychotics in adolescents with acute psychotic episodes. Methods We examined the associations of pharmacogenetic factors with the efficacy and safety of antipsychotics in 101 adolescents with acute psychotic episodes. The diagnosis on admission was “Brief psychotic disorder” (F23.0–23.9 by ICD-10). All patients were administered antipsychotics for 14 days. Treatment efficacy and safety were assessed using the PANSS, CGAS, CGI-S(I), UKU SERS, BARS, and SAS scales. Pharmacokinetic genotyping was performed for the CYP2D6*4, *10, ABCB1 1236C>T, 2677G>T, and 3435C>T genes. Results CYP2D6 intermediate metabolisers had “Micturition disturbances” more often than extensive metabolisers (24.2 vs. 7.4%; p=0.026). “Wild” homozygote ABCB1 3435C>T CC was associated with more prominent akathisia. Haplotype analysis of three ABCB1 polymorphisms revealed that the “wild” alleles “C-G-C” (ABCB1 1236-2677-3435) were associated with higher risk of “Reduced salivation” (OR=2.95; 95% CI=1.35–6.45; p=0.0078). Conclusions CYP2D6 intermediate metabolism was associated with the risk of urinary difficulties under treatment with antipsychotics. We found that “wild” homozygotes ABCB1 1236C>T, 2677G>T, and 3435C>T were predictors of adverse drug effects caused by treatment with antipsychotics.


2021 ◽  
Vol 15 (06) ◽  
pp. 787-790
Author(s):  
Hana Khairina Putri Faisal ◽  
Feni Fitriani Taufik ◽  
Tribowo Tuahta Ginting Sugihen ◽  
Prasenohadi ◽  
Tomu Juliani ◽  
...  

Introduction: COVID-19 pandemic affects mental health globally. Reports showed the increase of mental illness as a response to the COVID-19 pandemic. However, the correlation between the COVID-19 and mental illness is not fully understood yet. Methodology: We reported a brief psychotic disorder in a COVID-19 patient with no history of mental illness who was hospitalized in Persahabatan Hospital, Jakarta, Indonesia. Results: Psychotic symptoms appeared five days after COVID-19 onset and laboratory tests showed elevated levels of d-dimer and fibrinogen. Conclusions: Elevated levels of d-dimer and fibrinogen suggest an ongoing COVID-19-associated coagulopathy that might cause a microdamage in the central nervous system. It might contribute to the manifestation of psychotic symptoms. The correlation between brief psychotic disorder and COVID-19 requires further investigation.


Cureus ◽  
2021 ◽  
Author(s):  
Nischit Baral ◽  
Govinda Adhikari ◽  
Sandip Karki ◽  
Andrew Champine ◽  
Parul Sud

2021 ◽  
Vol 63 (5) ◽  
pp. 508
Author(s):  
EsraAydin Sunbul ◽  
EmineCengiz Cavusoglu ◽  
Huseyin Gulec

Sign in / Sign up

Export Citation Format

Share Document